2.81
Revelation Biosciences Inc 주식(REVB)의 최신 뉴스
Revelation Biosciences (REVB) to Release Earnings on Friday - Defense World
REVB stock touches 52-week low at $2.71 amid sharp annual decline - Investing.com
REVB stock touches 52-week low at $2.71 amid sharp annual decline By Investing.com - Investing.com South Africa
Revelation Biosciences: Gemini priming attenuates inflammatory response in PBMCs - TipRanks
Gemini Priming Attenuates Inflammation In Human Peripheral Blood Mononuclear Cells - Marketscreener.com
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells - Business Wire
Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews
Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference - Business Wire
What is Roth Capital’s Estimate for REVB FY2029 Earnings? - Defense World
REVB: 2025 Is the Year for Measurable Progress - Research Tree
Revelation Biosciences Inc. (REVB) reports earnings - Quartz
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024 - WICZ
Can Revelation's $6.5M Cash Runway Support Its Promising Gemini Program? - Stock Titan
Revelation Biosciences stock hits 52-week low at $3.26 By Investing.com - Investing.com South Africa
Revelation Biosciences stock hits 52-week low at $3.26 - Investing.com
Revelation Biosciences Doses First Patient In Prime Phase 1B Clinical Study Of Gemini In CKD Patients - Marketscreener.com
Revelation doses first patient in PRIME Phase 1b clinical study - TipRanks
Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients - Business Wire
Artificial Intelligence (AI) News Live Feed - StockTitan
Revelation Biosciences gets continued listing approval from Nasdaq - MSN
Revelation Biosciences Says Regained Compliance With Nasdaq Minimum Bid Price Requirement - MarketScreener
Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval - Business Wire
Can This Biotech's New Kidney Disease Trial Transform CKD Treatment? Key Details - Stock Titan
Larchmont broker accused of years-long insider trading scheme - Westfair Online
Allergic Rhinitis Market Expected to rise, 2034 | Regeneron, - openPR
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Neumora Therapeutics, Rain Oncology, and Carmell Corporation: Stock Volatility Highlights Major Market Moves - HPBL
Allergic Rhinitis Market to Show Remarkable Growth Trends from - openPR
Revelation Biosciences stock hits 52-week low at $0.28 - MSN
REVB Start 1B Trial and Announces Split - MSN
REVB: Phase 1b Begins and Nasdaq Compliance Regained - Research Tree
Stock market news: MiNK Therapeutics -93.51%, Revelation Biosciences -93.45% among biggest losers during mid day trading - Business Upturn
Stock market news: Vincerx Pharma plunged by 95.86% while MiNK Therapeutics was down by 94.26% during mid day trading - Business Upturn
Stock market today: Revelation Biosciences -93.16%, MiNK Therapeutics -91.40% among biggest losers in early trading - Business Upturn
Stock market today: Vincerx Pharma declined by 95.75% whereas Revelation Biosciences - Business Upturn
Revelation Biosciences Inc (REVB) Has Strong Growth Prospects Through 2025 - Marketing Sentinel
Anthem man charged with insider trading - Foothills Focus
Revelation Biosciences stock hits 52-week low at $0.28 By Investing.com - Investing.com Canada
Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025 - BioSpace
Revelation Biosciences to effect 1-for-16 reverse stock split to regain Nasdaq compliance - MSN
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients - Marketscreener.com
Revelation Bio Launches Phase 1b Trial of Gemini for Advanced Chronic Kidney Disease Treatment - Stock Titan
Florida Trader Among 4 Arrested for 7-Year-Long Insider Trading Scheme - NewsBreak
Revelation Biosciences (REVB) Price Target Increased by 242.79% to 40.04 - MSN
Broker, Traders Charged With $1M Insider Trading Scheme - Law360
Personal Finance - Business Wire
Several More Companies Propose Move From Delaware To Nevada - JD Supra
자본화:
|
볼륨(24시간):